Latest News Archive
Please select Category, Year, and then Month to display items
21 April 2021
|
Story Eugene Seegers
|
Photo Supplied
Adelia Chauque graduated with distinction during the April Virtual Graduations hosted by the UFS.
On 20 April 2021, 693
South Campus students graduated during a
virtual ceremony, with 213 of them achieving distinctions. One of these is
Adelia Chauque, the newly elected South Campus SRC member for Policy and Transformation. During her journey as a student, Adelia says that she had numerous obstacles to overcome. For instance, she mentions that her “biggest challenge was completing my tasks with an unstable data connection during the pandemic”. Despite this impediment, Adelia managed to excel in her studies and obtained her qualification with distinction.
Adelia says her family was her biggest support system. “Due to the network problems that I faced my family had to drive me around until we found a stable connection that enabled me to write my tests.” Other support came from the university itself. “I received a lot of support from the academic adviser, Mr Chwaro Shuping,” she says. “Although he couldn't arrange for me to return to campus, he called regularly to ensure that I was still academically active.”
After overcoming these hurdles, Adelia is continuing her academic journey. “I am enthusiastic and eager to learn or to better myself. Due to that, I am furthering my studies by enrolling for a second degree programme in
Administration majoring in Industrial Psychology. I am very ambitious, in the sense that I strive for perfection and consistency with an organised and maintainable future, therefore being part of the SRC enables me to assist students and myself with a secured and comfortable learning environment to achieve our goals at the institution.”
Adelia balances her responsibilities in the SRC portfolio of Policy and Transformation on the South Campus by having a schedule planned that ensures she does not fall behind. She concludes, “During the morning, I attend my prescribed lectures to ensure that I will continue to slay academically. Then I am visible in the SRC office from 12:00 to 16:30. After hours, I contribute my time to study, but I remain available to students who prefer texting.” The university is keen to see the heights to which Adelia will attain in the coming years.
“I am enthusiastic and eager
to learn or to better myself.”
Adelia Chauque, South Campus SRC:
Policy and Transformation.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004